Tesamorelin
Tesamorelin is a synthetic analogue of GHRH (growth-hormone-releasing hormone). It is studied in preclinical and clinical research in relation to GH/IGF-1 signalling and visceral fat metabolism.
What is Tesamorelin?
Tesamorelin is a synthetic analogue of GHRH (growth-hormone-releasing hormone). It is studied in preclinical and clinical research in relation to GH/IGF-1 signalling and visceral fat metabolism. This page is intended solely as an informational research guide for laboratory applications (Research Use Only).
Mechanism (preclinical)
Binds the GHRH receptor on the pituitary and stimulates endogenous GH release in models.
Research areas
- Growth hormone and IGF-1 research
- Visceral fat metabolism (preclinical)
- Lipid metabolism
- GHRH receptor research
Specifications
- Molecular weight
- 5195,80 g/mol
- Purity
- ≥ 99%
- Form
- Lyophilised powder
- Included
- 3 ml bacteriostatic water
Storage and reconstitution
Dry (lyophilised) powder can be stored long-term at -20 to -80 °C in an airtight, opaque container. After reconstitution with bacteriostatic water the solution must be refrigerated at 2 to 8 °C and protected from light.
Order Tesamorelin from Europa Peptides
Europa Peptides supplies Tesamorelin as lyophilised powder with ≥ 99% purity - 3 ml bacteriostatic water included. Shipped from our Netherlands warehouse. Orders placed before 16:00 on a business day ship the same day. For laboratory research only (RUO).